Xenon Pharmaceuticals Inc. SEC filings XENE
Xenon Pharmaceuticals Inc. has 800 filings in SEC EDGAR's recent list, going back to Aug 16, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| CT ORDER | Filing | Sep 1, 2020 | — |
| EFFECT | Filing | Jun 12, 2020 | — |
| CORRESP | Letter to the SEC | Jun 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 27, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| CT ORDER | Filing | Sep 11, 2019 | — |
| CT ORDER | Filing | Sep 11, 2019 | — |
| EFFECT | Filing | Aug 15, 2019 | — |
| CORRESP | Letter to the SEC | Aug 13, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2019 | — |
| CT ORDER | Filing | Dec 17, 2018 | — |
| CT ORDER | Filing | Sep 11, 2018 | — |
| CT ORDER | Filing | Apr 18, 2018 | — |
| CT ORDER | Filing | Feb 1, 2018 | — |
| CT ORDER | Filing | Sep 18, 2017 | — |
| CT ORDER | Filing | Sep 5, 2017 | — |
| CT ORDER | Filing | Jul 28, 2016 | — |
| CT ORDER | Filing | Apr 27, 2016 | — |
| EFFECT | Filing | Jan 5, 2016 | — |
| CORRESP | Letter to the SEC | Dec 30, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2015 | — |
| CT ORDER | Filing | Oct 6, 2015 | — |
| CT ORDER | Filing | Nov 7, 2014 | — |
| EFFECT | Filing | Nov 4, 2014 | — |
| CORRESP | Letter to the SEC | Nov 3, 2014 | — |
| CERTNAS | Auto-generated paper document | Oct 16, 2014 | — |
| CORRESP | Letter to the SEC | Oct 14, 2014 | — |
| CORRESP | Letter to the SEC | Oct 14, 2014 | — |
| 8-A12B | Filing | Oct 10, 2014 | — |
| CORRESP | Letter to the SEC | Oct 8, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2014 | — |
| CORRESP | Letter to the SEC | Sep 29, 2014 | — |
| CORRESP | Letter to the SEC | Sep 29, 2014 | — |
| CORRESP | Letter to the SEC | Sep 24, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2014 | — |
| DRSLTR | Filing | Aug 20, 2014 | — |
| DRS/A | Filing | Aug 20, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2014 | — |
| DRS/A | Filing | Mar 19, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2013 | — |
| DRS/A | Filing | Sep 25, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2013 | — |
| DRS | Filing | Aug 16, 2013 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XENE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Burnaby
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1582313
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.